A review of current antibiotic resistance and promising antibiotics with novel modes of action to combat antibiotic resistance
- PMID: 37863957
- DOI: 10.1007/s00203-023-03699-2
A review of current antibiotic resistance and promising antibiotics with novel modes of action to combat antibiotic resistance
Abstract
The emergence and transmission of antibiotic resistance is a global public health crisis with significant burden on healthcare systems, resulting in high mortality and economic costs. In 2019, almost five million deaths were associated with drug-resistant infections, and if left unchecked, the global economy could lose $100 trillion by 2050. To effectively combat this crisis, it is essential for all countries to understand the current situation of antibiotic resistance. In this review, we examine the current driving factors leading to the crisis, impact of critical superbugs in three regions, and identify novel mechanisms of antibiotic resistance. It is crucial to monitor the phenotypic characteristics of drug-resistant pathogens and describe the mechanisms involved in preventing the emergence of cross-resistance to novel antimicrobials. Additionally, maintaining an active pipeline of new antibiotics is essential for fighting against diverse antibiotic-resistant pathogens. Developing antibacterial agents with novel mechanisms of action is a promising way to combat increasing antibiotic-resistant pathogens.
Keywords: Antibiotic resistance; Factors; Impact; Mechanisms; Novel antibiotic candidates.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Reviewing on AI-Designed Antibiotic Targeting Drug-Resistant Superbugs by Emphasizing Mechanisms of Action.Drug Dev Res. 2025 Feb;86(1):e70066. doi: 10.1002/ddr.70066. Drug Dev Res. 2025. PMID: 39932058 Review.
-
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision.Expert Rev Anti Infect Ther. 2022 Oct;20(10):1309-1332. doi: 10.1080/14787210.2022.2122442. Epub 2022 Sep 28. Expert Rev Anti Infect Ther. 2022. PMID: 36069241 Review.
-
Antibiotic-non-antibiotic combinations for combating extremely drug-resistant Gram-negative 'superbugs'.Essays Biochem. 2017 Mar 3;61(1):115-125. doi: 10.1042/EBC20160058. Print 2017 Feb 28. Essays Biochem. 2017. PMID: 28258235 Review.
-
Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal.Expert Rev Anti Infect Ther. 2022 Aug;20(8):1095-1108. doi: 10.1080/14787210.2022.2078308. Epub 2022 May 31. Expert Rev Anti Infect Ther. 2022. PMID: 35576494 Review.
-
Bismuth Drugs Reverse Tet(X)-Conferred Tigecycline Resistance in Gram-Negative Bacteria.Microbiol Spectr. 2022 Feb 23;10(1):e0157821. doi: 10.1128/spectrum.01578-21. Epub 2022 Feb 9. Microbiol Spectr. 2022. PMID: 35138168 Free PMC article.
Cited by
-
Antibiotic resistance challenge: evaluating anthraquinones as rifampicin monooxygenase inhibitors through integrated bioinformatics analysis.Genomics Inform. 2024 Sep 4;22(1):13. doi: 10.1186/s44342-024-00015-2. Genomics Inform. 2024. PMID: 39232833 Free PMC article.
-
Screening of promising molecules against potential drug targets in Yersinia pestis by integrative pan and subtractive genomics, docking and simulation approach.Arch Microbiol. 2024 Sep 25;206(10):415. doi: 10.1007/s00203-024-04140-y. Arch Microbiol. 2024. PMID: 39320535
-
Resistance profiles of Staphylococcus aureus isolates against frequently used antibiotics at private sector laboratories in Jordan.Iran J Microbiol. 2025 Apr;17(2):229-238. doi: 10.18502/ijm.v17i2.18382. Iran J Microbiol. 2025. PMID: 40337673 Free PMC article.
-
Identification of Antimicrobial-Resistant Zoonotic Bacteria in Swine Production: Implications from the One Health Perspective.Antibiotics (Basel). 2024 Sep 13;13(9):883. doi: 10.3390/antibiotics13090883. Antibiotics (Basel). 2024. PMID: 39335056 Free PMC article.
-
The Invisible Threat of Antibiotic Resistance in Food.Antibiotics (Basel). 2025 Mar 1;14(3):250. doi: 10.3390/antibiotics14030250. Antibiotics (Basel). 2025. PMID: 40149061 Free PMC article. Review.
References
-
- Al-Tawfiq JA, Momattin H, Al-Ali AY et al (2022) Antibiotics in the pipeline: a literature review (2017–2020). Infection 50:553–564. https://doi.org/10.1007/s15010-021-01709-3 - DOI - PubMed
-
- Andrei S, Droc G, Stefan G (2019) FDA approved antibacterial drugs: 2018–2019. Discoveries 7:e102. https://doi.org/10.15190/d.2019.15 - DOI - PubMed - PMC
-
- Asokan G, Ramadhan T, Ahmed E, Sanad H (2019) WHO global priority pathogens list: a bibliometric analysis of Medline-Pubmed for knowledge mobilization to infection prevention and control practices in Bahrain. Oman Med J 34:184–193. https://doi.org/10.5001/omj.2019.37 - DOI - PubMed - PMC
-
- Ayikpoe RS, Shi C, Battiste AJ et al (2022) A scalable platform to discover antimicrobials of ribosomal origin. Nat Commun 13:6135. https://doi.org/10.1038/s41467-022-33890-w - DOI - PubMed - PMC
-
- Biswas S (2023) Synthesis of a novel lantibiotic using mutacin II biosynthesis apparatus. Microbiol Spectr. https://doi.org/10.1128/spectrum.03030-22 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical